Pharmacy Times May 24, 2022

Murray Aitken, executive director of IQVIA Institute for Human Data Science, discusses the implications of the increase in spending on medicines in the United States in 2021.

Pharmacy Times interviewed Murray Aitken, executive director of IQVIA Institute for Human Data Science, on the increase in spending on medicines in 2021 in the United States and implications for the US health care system.

Alana Hippensteele: Hi, I’m Alana Hippensteele with Pharmacy Times. Joining me is Murray Aitken, executive director of IQVIA Institute for Human Data Science, who is here to discuss the increase in spending on medicines in 2021 in the United States.

So Murray, how much did spending on US medicines increase, and why might this increase have occurred?

Murray...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Biotechnology, Healthcare System, Interview / Q&A, Pharma, Pharma / Biotech, Pricing / Spending, Trends
Related Articles:
Biopharma M&A more than doubled in the first quarter compared to the year prior: report
23andMe: What If …
Bruker brokers $392M deal for frayed NanoString
Pharma Pulse 4/18/24: Is it Fair Certain Biotech Investors Get an Early Look? The Health and Healthcare of Millennials & more
Pharmacies Should Adopt Proactive Health, Wellness to Help Patients

Share This Article